World biopharmaceutical firm Takeda not too long ago hosted the occasion “Innovation and Hope: Connecting Minds to Remodel HAE Affected person Care” within the area, uniting healthcare professionals to debate modern therapies and collaborative methods for managing Hereditary Angioedema (HAE) within the Center East.
Hereditary Angioedema (HAE) is a uncommon genetic dysfunction affecting roughly 1 in 50,000 people worldwide. It’s characterised by recurrent episodes of swelling in numerous elements of the physique, together with the face, neck, and throat. Signs might be unpredictable and should happen at any age and swelling of the higher airways might be notably harmful and should result in deadly asphyxiation. HAE assaults can last as long as 5 days and should unfold to a different location earlier than resolving, and might be triggered by components reminiscent of stress, accidents, hormonal modifications, and dental procedures. Signs usually worsen over the primary 24 hours and subside over the subsequent 48–72 hours. These unpredictable signs can result in extreme issues, making well timed analysis and therapy essential.
To deal with the gaps in HAE analysis and therapy within the UAE, this occasion showcased main HAE healthcare consultants from the area via a collection of plenary periods and panel discussions. These periods raised consciousness of each the scientific and societal dimensions of HAE care. It primarily centered on the nuances of native healthcare methods and analysis and therapy protocols, whereas additionally presenting the newest real-world case research, scientific findings, and analysis to enhance the lives of HAE sufferers.
“We take delight in bringing collectively healthcare professionals and affected person advocates for ‘Innovation and Hope: Connecting Minds to Remodel HAE Affected person Care’.It highlighted our dedication to enhancing the analysis and therapy of Hereditary Angioedema within the UAE. By means of fostering collaboration and sharing developments in care, we intention to enhance well being outcomes for sufferers and their households,” mentioned,Ahmed Fayed,Normal Supervisor, Takeda East Gulf and Levant Cluster
Professor Mohamed Abuzakouk, Marketing consultant in Medical Immunology and Allergy and Chairman of the Gulf Academy Convention on Allergy and Medical Immunology 2025, Abu Dhabi, UAE, said, “The administration of Hereditary Angioedema continues to evolve with occasions like these, and the collaboration between healthcare professionals, researchers, and affected person advocates is essential for bettering affected person care. By embracing superior therapy choices, we’re providing hope to sufferers and their households, enabling them to dwell more healthy, extra secure lives with out the fixed worry of debilitating assaults.”
Takeda is devoted to enhancing entry to HAE remedies throughout the Center East by fostering regional collaborations and implementing tailor-made affected person care approaches. The emphasis will stay on each short-term and long-term methods to make sure sustainable enhancements in HAE administration, in the end benefiting sufferers and their households within the area.
